Home / Market News / $SENS

$SENS news and market catalysts

The 12 most recent market catalysts affecting $SENS, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

12 catalysts 2 high impact 7 bullish 2 bearish Medical Devices
Nov 14, 2026 Corporate Catalyst Bullish Impact 75
Analysts Update 2027 Forecasts and Price Targets for Senseonics Holdings
Analysts have updated their financial models for Senseonics Holdings (SENS) after the company's third-quarter results. This led to an upward revision of 2027 revenue forecasts from…
Nov 10, 2026 Corporate Catalyst Bullish Impact 65
Raymond James Upgrades Senseonics to Market Perform
Raymond James upgraded Senseonics Holdings, Inc. from Underperform to Market Perform after the company's Q3 2026 earnings report. This upgrade is significant as it reflects a more …
Nov 10, 2026 Corporate Catalyst Bullish Impact 55
Raymond James Upgrades Senseonics to Market Perform
Raymond James upgraded Senseonics Holdings, Inc. from Underperform to Market Perform. This change signifies that the analyst firm no longer views the stock as likely to underperfor…
Nov 9, 2026 Corporate Catalyst Bullish Impact 85
Senseonics Holdings, Inc. Reports Third Quarter 2026 Financial Results
Senseonics Holdings reported a substantial 140% year-over-year increase in Q3 2026 revenue, reaching $19.6 million. This strong performance led the company to raise its full-year 2…
Oct 26, 2026 Corporate Catalyst Neutral Impact 65
Senseonics Initiates First-in-Human Clinical Study for Freedom CGM System
Senseonics Holdings, Inc. has initiated the first-in-human clinical study for its Freedom CGM system, a significant milestone in its product development. This system aims to differ…
Oct 7, 2026 Corporate Catalyst Neutral Impact 55
Barclays Initiates Coverage On Senseonics Holdings with Equal-Weight Rating, Announces Price Target of $10
Barclays analyst Christopher Pasquale initiated coverage on Senseonics Holdings (SENS) with an 'Equal-Weight' rating and a $10 price target. This event is significant because new a…
Sep 14, 2026 Corporate Catalyst Bullish Impact 65
Senseonics Partners With Beta Bionics To Integrate Its Eversense 365 CGM With Beta Bionics’ iLet Bionic Pancreas Automated Insulin Delivery System
Senseonics has announced a partnership with Beta Bionics to integrate its Eversense 365 Continuous Glucose Monitoring (CGM) system with Beta Bionics' iLet Bionic Pancreas Automated…
Aug 10, 2026 Corporate Catalyst Bullish Impact 85
Senseonics Holdings shares are trading higher after the company reported better-than-expected Q2 sales results and raised its FY26 sales guidance with its midpoint above estimates.
This headline represents a strong positive corporate catalyst for Senseonics Holdings. Better-than-expected sales and an increased long-term guidance signal improving operational p…
Aug 10, 2026 Corporate Catalyst Neutral Impact 75
CORRECTION: Senseonics Holdings Reported Q2 Financial Results On Aug. 6, 2026
The 'CORRECTION' aspect of this headline is crucial. It suggests that the market may have previously reacted to incorrect information or is now being alerted to a definitive date f…
Aug 6, 2026 Corporate Catalyst Bullish Impact 75
Senseonics Holdings Raises FY2026 Sales Guidance from $60.000M-$64.000M to $62.000M-$66.000M vs $62.117M Est
Senseonics Holdings filed an 8-K to announce an upward revision to its fiscal year 2026 sales guidance. The company now expects sales to be between $62.0 million and $66.0 million,…
Aug 6, 2026 Corporate Catalyst Bearish Impact 75
Senseonics Holdings Q2 EPS $(0.63), Inline, Sales $14.483M Beat $12.871M Estimate
Senseonics Holdings announced its Q2 earnings, reporting an EPS of $(0.63) which was in line with analyst estimates. More notably, the company's sales of $14.483 million significan…
Jul 15, 2026 Corporate Catalyst Bearish Impact 60
Mizuho Maintains Outperform on Senseonics Holdings, Lowers Price Target to $18
Mizuho analyst Anthony Petrone maintained an 'Outperform' rating for Senseonics Holdings, signaling continued confidence in the company's fundamentals. However, the price target wa…
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.